First Opinion By Amanda Joy Calhoun Beyond awareness: The medical system needs to deeply reform its care of people with autism
First Opinion By Kristin E. Rojas The FDA needs to take another look at laser-based ‘vaginal rejuvenation’
First Opinion By Rachel Burr Gerrard There’s no autism epidemic. But there is an autism diagnosis epidemic
Heavyweights By Lev Facher ‘I’m going to prove you wrong’: How a D.C. power couple used an ALS diagnosis to create a political juggernaut
First Opinion By Jeremy Menchik Confessions of a ‘human guinea pig’: Why I’m resigning from Moderna vaccine trials
First Opinion By David Introcaso Deaths of despair: the unrecognized tragedy of working class immiseration
First Opinion Podcast By Patrick Skerrett Listen: The faces of Covid at 1 million deaths and counting
D.C. Diagnosis By Nicholas Florko As Congress takes up FDA oversight of dietary supplements, a lobbying showdown looms
First Opinion By Joe Lieberman and Michelle McMurry-Heath Russian aggression underscores the U.S.’s need for greater investment in medical countermeasures
First Opinion By Fiona Hathorn ‘Boards for All?’ Global health organizations and companies aren’t even close
Politics By Rachel Cohrs Manchin won’t support new health policy unless Congress rolls back Trump tax cuts
Politics By Nicholas Florko Right to try 2.0: Advocates want to reduce oversight of ‘n of 1’ therapies
First Opinion Podcast By Patrick Skerrett Listen: Covid turned the nation’s eyes to nursing homes. Have we already looked away?
First Opinion By Shikha Jain, Vineet Arora and Eve Bloomgarden The ‘bot holiday’ and why clinicians can’t tackle disinformation alone
First Opinion Podcast By Patrick Skerrett Listen: Should gender dysphoria be a required stop en route to gender euphoria?
First Opinion Podcast By Patrick Skerrett Listen: Pharma companies market their drugs to young adults — so why don’t they include them in clinical trials?
First Opinion By Paul Knoepfler Google’s ongoing stem cell problem points to a larger issue with its search results on unproven therapies
First Opinion By John C. Messinger, Anand Chukka and J. Wesley Boyd The case for decriminalizing the street sale of buprenorphine
First Opinion By Peter Pronovost Checklists work well for complicated health care problems. But they don’t work to solve complex ones, like pandemics
First Opinion By Sneha Dave If pharma can market to youths by TikTok, it should include them in clinical trials
First Opinion By Emma Biegacki Emergency response systems must not overlook people with substance use disorders
First Opinion Podcast By Patrick Skerrett Listen: The ‘underground market’ for insulin and diabetes supplies
D.C. Diagnosis By Nicholas Florko Inside the push for a permanent pandemic preparedness office at the White House
First Opinion By Bill Frist, Jerome M. Adams and Jerold Mande Commissioner Califf needs to put the F back in FDA
First Opinion By Richard J. Baron and Ezekiel J. Emanuel Politicians should not be deciding what constitutes good medicine
First Opinion By Bret Mettler Sunsetting medical license reciprocity would return medicine to the dark ages
First Opinion By Bruce Farber and Aradhana Khameraj Health care workers don unnecessary protective gear. The CDC and WHO need to update their PPE guidance